Key result
Beta-blocker therapy enables successful ICD cardioversion of VT and prevents shock-induced tachycardia acceleration.
Why the study?
The proarrhythmic potential of ICD shocks under varying sympathetic tone in patients with drug-refractory ventricular tachyarrhythmias is not well understood.
Does increased sympathetic discharge enhance the proarrhythmic potential of ICD shocks in a patient with ventricular tachyarrhythmias?
Case Report (n=1)
Does increased sympathetic discharge enhance the proarrhythmic potential of ICD shocks in a patient with ventricular tachyarrhythmias?
Increased sympathetic discharge, such as from missed beta-blocker doses and exercise, may enhance the proarrhythmic potential of ICD shocks, leading to accelerated ventricular tachycardia.
Nonadherence to beta-blockers may precipitate refractory VT with failed ICD shocks; hypothesis-generating in this Level 5 case.
A 72-year old male with an old myocardial infarction who had drug-refractory ventricular tachyarrhythmias received an implantable cardioverter-defibrillator (ICD). The patient did not take his prescribed beta-blocking agent for two days, following which he experienced six discrete shocks for spontaneous VT while riding his bicycle. Both 5J and 30J cardioversions were ineffective at terminating the VT and accelerated VT developed following the shocks. After admission, an electrophysiological study was performed while he was taking the beta-blocking agent, both low and high energy cardioversions reproducibly terminated the clinical VT without showing any accelerated rhythm. These findings suggest that the increase in sympathetic discharge may enhance the proarrhythmic potential of ICDs.
No takes yet. Share an insight, caveat, or question.
Washizuka et al. (1999) conducted a case report in Ventricular tachyarrhythmias (n=1). Low and high energy cardioversion without beta-blocker therapy vs. Cardioversion while on beta-blocker therapy was evaluated on Termination of ventricular tachycardia and development of accelerated ventricular tachycardia. In a patient off beta-blockers, both low and high energy ICD cardioversions failed to terminate VT and induced accelerated VT, whereas cardioversion on beta-blockers successfully terminated VT.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: